These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6821043)
1. [The use of oral futraful as secondary treatment of patients with metastatic carcinoma]. Labianca R; Beretta G; Luporini G G Ital Chemioter; 1982; 29(1):55-8. PubMed ID: 6821043 [No Abstract] [Full Text] [Related]
2. [Limits and possibilities of cytostatic therapy with massive doses of cyclophosphamide]. Chiarelli G; Garutti GP; Rambaldi P Arcisp S Anna Ferrara; 1967; 20(3):385-400. PubMed ID: 5606860 [No Abstract] [Full Text] [Related]
3. [Use of ftorafur in disseminated breast cancer]. Smolianskaia AZ; Romanenko NV Klin Med (Mosk); 1978 May; 56(5):52-6. PubMed ID: 351290 [No Abstract] [Full Text] [Related]
4. [A combined immuno-chemotherapy with futraful and picibanil for advanced cancer (author's transl)]. Sawai K; Sonoda Y; Ohkuma S; Misawa S; Takino T Nihon Gan Chiryo Gakkai Shi; 1977 Sep; 12(3):328-35. PubMed ID: 335004 [No Abstract] [Full Text] [Related]
5. Ftorafur in the treatment of advanced malignancies. Shetty PA; De Souza LJ; Jussawalla DJ Indian J Cancer; 1982; 19(3):159-60. PubMed ID: 6816720 [No Abstract] [Full Text] [Related]
7. [Treatment of 37 surgical cancers with associated or isolated chemotherapy]. Montezin J Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093 [No Abstract] [Full Text] [Related]
8. [Cooperative phase II study of spansule tegafur (SF-SP)]. Taguchi T Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs]. Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120 [TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma. Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577 [TBL] [Abstract][Full Text] [Related]
11. UFT: biochemical modulation for 5-fluorouracil (5-FU). Taguchi T Chin Med J (Engl); 1997 Apr; 110(4):294-6. PubMed ID: 9594232 [No Abstract] [Full Text] [Related]
12. [Ftorafur concentration in the blood and urine of oncological patients]. Blokhina NG; Smolianskaia AZ; Aledseev VM; Sokolova VD Vopr Onkol; 1977; 23(8):33-7. PubMed ID: 333748 [TBL] [Abstract][Full Text] [Related]
14. Clinical trials with oral Futraful (INN: Tegafur) in cancer of the head and neck. Inuyama Y; Horiuchi M; Kohno N; Mashino S; Ozu R; Asaoka K Clin Oncol; 1981 Jun; 7(2):131-9. PubMed ID: 6265131 [No Abstract] [Full Text] [Related]
15. [Comments on the treatment of solid tumors with 5-fluorouracil]. Alberto P Ther Umsch; 1969 Jul; 26(7):415-21. PubMed ID: 4308282 [No Abstract] [Full Text] [Related]
16. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors]. Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992 [No Abstract] [Full Text] [Related]
17. Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature. Nathanson L; Hall TC; Schilling A; Miller S Cancer Res; 1969 Feb; 29(2):419-25. PubMed ID: 4885390 [No Abstract] [Full Text] [Related]
18. [On intralymphatic administration of antineoplastic agents]. Porzio R; Giannattasio G; Carbone R; Di Stefano G Minerva Med; 1970 May; 61(43):2405-16. PubMed ID: 5425727 [No Abstract] [Full Text] [Related]
19. High-dose therapy with ftorafur in gastrointestinal cancer. Klein HO; Wickramanayake PD; Voigtmann R; Löffler T; Mohr R; Oerkermann H Recent Results Cancer Res; 1981; 79():65-81. PubMed ID: 6795700 [No Abstract] [Full Text] [Related]
20. [Characteristic pharmacodynamic in 1-(2-tetrahydrofuryl)-5-fluorouracil metabolism and its clinical efficacy in patients with primary hepatoma (author's transl)]. Watanabe A; Hobara N; Nagashima H Nihon Shokakibyo Gakkai Zasshi; 1978 Dec; 75(12):1947-59. PubMed ID: 216825 [No Abstract] [Full Text] [Related] [Next] [New Search]